Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Immunol ; 24(6): 991-1006, 2023 06.
Article in English | MEDLINE | ID: mdl-37095377

ABSTRACT

Germinal center (GC) B cells undergo proliferation at very high rates in a hypoxic microenvironment but the cellular processes driving this are incompletely understood. Here we show that the mitochondria of GC B cells are highly dynamic, with significantly upregulated transcription and translation rates associated with the activity of transcription factor A, mitochondrial (TFAM). TFAM, while also necessary for normal B cell development, is required for entry of activated GC precursor B cells into the germinal center reaction; deletion of Tfam significantly impairs GC formation, function and output. Loss of TFAM in B cells compromises the actin cytoskeleton and impairs cellular motility of GC B cells in response to chemokine signaling, leading to their spatial disorganization. We show that B cell lymphoma substantially increases mitochondrial translation and that deletion of Tfam in B cells is protective against the development of lymphoma in a c-Myc transgenic mouse model. Finally, we show that pharmacological inhibition of mitochondrial transcription and translation inhibits growth of GC-derived human lymphoma cells and induces similar defects in the actin cytoskeleton.


Subject(s)
Lymphoma, B-Cell , Lymphoma , Mice , Humans , Animals , B-Lymphocytes/pathology , Germinal Center/pathology , Transcription, Genetic , Lymphoma, B-Cell/genetics , Lymphoma, B-Cell/pathology , Mice, Transgenic , Tumor Microenvironment
2.
Front Immunol ; 12: 681105, 2021.
Article in English | MEDLINE | ID: mdl-34163480

ABSTRACT

B cells are central to the pathogenesis of multiple autoimmune diseases, through antigen presentation, cytokine secretion, and the production of autoantibodies. During development and differentiation, B cells undergo drastic changes in their physiology. It is emerging that these are accompanied by equally significant shifts in metabolic phenotype, which may themselves also drive and enforce the functional properties of the cell. The dysfunction of B cells during autoimmunity is characterised by the breaching of tolerogenic checkpoints, and there is developing evidence that the metabolic state of B cells may contribute to this. Determining the metabolic phenotype of B cells in autoimmunity is an area of active study, and is important because intervention by metabolism-altering therapeutic approaches may represent an attractive treatment target.


Subject(s)
Autoimmunity , Autophagy , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Energy Metabolism , Autoimmune Diseases/diagnosis , Autoimmune Diseases/etiology , Autoimmune Diseases/metabolism , Autoimmune Diseases/therapy , B-Lymphocytes/cytology , Biomarkers , Disease Susceptibility , Humans , Lymphocyte Activation/immunology , Lymphopoiesis , Molecular Targeted Therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...